Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
Mustang Bio
Columbia University
M.D. Anderson Cancer Center
Indiana University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Baylor College of Medicine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Targazyme, Inc.
M.D. Anderson Cancer Center
Baylor College of Medicine
OHSU Knight Cancer Institute
Asan Medical Center